Showing results (41-50 of 95) with videos related to
Sort By:
Pageof 10
Journal of Virology|December 1, 1991
Analysis of trans-acting response decoy RNA-mediated inhibition of human immunodeficiency virus type 1 transactivationB A Sullenger, H F Gallardo, G E Ungers, et al.Cell|November 2, 1990
Overexpression of TAR sequences renders cells resistant to human immunodeficiency virus replicationB A Sullenger, H F Gallardo, G E Ungers, et al.Cancer Research|December 15, 1990
Retroviral vector-mediated gamma-interferon gene transfer into tumor cells generates potent and long lasting antitumor immunityB Gansbacher, R Bannerji, B Daniels, et al.Journal of Virology|May 1, 1981
Genome structure of Abelson murine leukemia virus variants: proviruses in fibroblasts and lymphoid cellsS P Goff, O N Witte, E Gilboa, et al.The Journal of Experimental Medicine|April 1, 1993
Regression of bladder tumors in mice treated with interleukin 2 gene-modified tumor cellsJ Connor, R Bannerji, S Saito, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 15, 1997
Intranasal immunization with CTL epitope peptides from HIV-1 or ovalbumin and the mucosal adjuvant cholera toxin induces peptide-specific CTLs and protection against tumor development in vivoA Porgador, H F Staats, B Faiola, et al.Leukemia|February 1, 1993
Development of a lacZ marked WEHI-3B D+ murine leukemic cell line as an in-vivo model of acute non-lymphocytic leukemiaC Smith, M O Muench, M Knizewski, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 15, 1993
Antimetastatic vaccination of tumor-bearing mice with two types of IFN-gamma gene-inserted tumor cellsA Porgador, R Bannerji, Y Watanabe, et al.Oncoimmunology|May 8, 2015
Reducing toxicity of 4-1BB costimulation: targeting 4-1BB ligands to the tumor stroma with bi-specific aptamer conjugatesB Schrand, A Berezhnoy, R Brenneman, et al.Cancer Research|January 1, 1991
Expression of functional epidermal growth factor receptors in a human hematopoietic cell lineJ Oval, R Hershberg, B Gansbacher, et al.Pageof 10